Cargando…

Analyses of risk factors for polycystic ovary syndrome complicated with non-alcoholic fatty liver disease

The risk factors related to polycystic ovary syndrome (PCOS) patients complicated with non-alcoholic fatty liver disease (NAFLD) were investigated. A total of 188 PCOS patients treated in Shengli Oilfield Central Hospital (Dongying, China) from February 2014 to February 2015 were retrospectively ana...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jianhai, Hu, Jian, Zhang, Chunxia, Jiao, Yanni, Kong, Xiang, Wang, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920378/ https://www.ncbi.nlm.nih.gov/pubmed/29725371 http://dx.doi.org/10.3892/etm.2018.5932

Ejemplares similares

Non-alcoholic fatty liver disease in polycystic ovary syndrome women
por: Won, Young Bin, et al.
Publicado: (2021)

Predictivity of fatty liver index for non-alcoholic fatty liver disease in lean females with polycystic ovary syndrome
por: Arıkan, Didem, et al.
Publicado: (2022)

Key Genes Associated With Non-Alcoholic Fatty Liver Disease and Polycystic Ovary Syndrome
por: Chen, Yong, et al.
Publicado: (2022)

Non-alcoholic fatty liver disease is associated with hyperandrogenism in women with polycystic ovary syndrome
por: Hong, So-hyeon, et al.
Publicado: (2023)

A Systematic Review of the Risk of Non-alcoholic Fatty Liver Disease in Women With Polycystic Ovary Syndrome
por: Shahbaz, Mahrukh, et al.
Publicado: (2022)

Polycystic Ovary Syndrome and Metabolic Syndrome: Clinical and Laboratory Findings and Non-Alcoholic Fatty Liver Disease Assessed by Elastography
por: Lavor, Claruza Braga Holanda, et al.
Publicado: (2022)

The Burden of Non-Alcoholic Fatty Liver Disease in Adolescents with Polycystic Ovary Syndrome: A Case–Control Study
por: Giannouli, Aikaterini, et al.
Publicado: (2023)

The hepato-ovarian axis: genetic evidence for a causal association between non-alcoholic fatty liver disease and polycystic ovary syndrome
por: Liu, Dong, et al.
Publicado: (2023)

Current Perspectives on Nonalcoholic Fatty Liver Disease in Women with Polycystic Ovary Syndrome
por: Wang, Dongxu, et al.
Publicado: (2022)

A potential link between polycystic ovary syndrome and non-alcoholic fatty liver disease: an update meta-analysis
por: Wu, Jia, et al.
Publicado: (2018)

Non‐alcoholic fatty liver disease in premenopausal women with polycystic ovary syndrome: A systematic review and meta‐analysis
por: Shengir, Mohamed, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease in a Sample of Iranian Women with Polycystic Ovary Syndrome
por: Mehrabian, Ferdous, et al.
Publicado: (2017)

Nonalcoholic Fatty Liver Disease in Polycystic Ovary Syndrome: A Race Against the Clock
por: Huffman, Alexandra M, et al.
Publicado: (2022)

Relationship between nonalcoholic fatty liver disease and hyperandrogenemia in adolescents with polycystic ovary syndrome
por: Kara, Ozlem, et al.
Publicado: (2023)

Non-Alcoholic Fatty Liver Disease in Patients with Polycystic Ovary Syndrome: A Systematic Review, Meta-Analysis, and Meta-Regression
por: Manzano-Nunez, Ramiro, et al.
Publicado: (2023)

Quercetin and polycystic ovary syndrome
por: Ma, Congshun, et al.
Publicado: (2022)

Icariin Alleviates Nonalcoholic Fatty Liver Disease in Polycystic Ovary Syndrome by Improving Liver Fatty Acid Oxidation and Inhibiting Lipid Accumulation
por: Hai, Yang, et al.
Publicado: (2023)

Association of non-alcoholic fatty liver disease and polycystic ovarian syndrome
por: Asfari, Mohammad Maysara, et al.
Publicado: (2020)

Screening and verification of genes related to polycystic ovary syndrome
por: Li, Xuebing, et al.
Publicado: (2023)

The relationship between polycystic ovary syndrome and infertility: a bibliometric analysis
por: Zhuang, Sulian, et al.
Publicado: (2022)

Prevalence and predictors of nonalcoholic fatty liver disease in South Asian women with polycystic ovary syndrome
por: Shengir, Mohamed, et al.
Publicado: (2020)

Polycystic Ovary Syndrome
por: Franks, Stephen
Publicado: (1998)

Complications and challenges associated with polycystic ovary syndrome: current perspectives
por: Palomba, Stefano, et al.
Publicado: (2015)

Expression of SET Protein in the Ovaries of Patients with Polycystic Ovary Syndrome
por: Boqun, Xu, et al.
Publicado: (2013)

Sex Hormone-Binding Globulin (SHBG) Reduction: The Alarm Bell for the Risk of Non-Alcoholic Fatty Liver Disease in Adolescents with Polycystic Ovary Syndrome
por: Urbano, Flavia, et al.
Publicado: (2022)

Potential Role of Quercetin in Polycystic Ovary Syndrome and Its Complications: A Review
por: Chen, Tong, et al.
Publicado: (2022)

SAT356 Predicting Nonalcoholic Fatty Liver Disease in Adolescent Girls with Polycystic Ovary Syndrome and Obesity
por: Lo, Jaclyn S, et al.
Publicado: (2023)

Meta-analysis of the efficacy of ω-3 polyunsaturated fatty acids when treating patients with polycystic ovary syndrome
por: Huang, Yue, et al.
Publicado: (2023)

Immunophenotypic Profiles in Polycystic Ovary Syndrome
por: Hu, Cong, et al.
Publicado: (2020)

Liver Injury Indicating Fatty Liver but Not Serologic NASH Marker Improves under Metformin Treatment in Polycystic Ovary Syndrome
por: Tan, Susanne, et al.
Publicado: (2015)

Serum fatty acid profiles associated with metabolic risk in women with polycystic ovary syndrome
por: Tian, Ye, et al.
Publicado: (2023)

Polycystic ovary syndrome and mitochondrial dysfunction
por: Zhang, Jingshun, et al.
Publicado: (2019)

Pregnancy in polycystic ovary syndrome
por: Kamalanathan, Sadishkumar, et al.
Publicado: (2013)

The inositols and polycystic ovary syndrome
por: Kalra, Bharti, et al.
Publicado: (2016)

On the Therapy for Polycystic Ovary Syndrome
por: Unfer, Vittorio, et al.
Publicado: (2017)

Kisspeptin and Polycystic Ovary Syndrome
por: Tang, Rong, et al.
Publicado: (2019)

Polycystic Ovary Syndrome in Adolescence
por: Deans, Rebecca
Publicado: (2019)

Update on polycystic ovary syndrome
por: Kim, Jin Ju
Publicado: (2021)

Prevalence, Risk Factors, and Pathophysiology of Nonalcoholic Fatty Liver Disease (NAFLD) in Women with Polycystic Ovary Syndrome (PCOS)
por: Spremović Rađenović, Svetlana, et al.
Publicado: (2022)

Whey Protein Supplementation Improves the Glycemic Response and May Reduce Non-Alcoholic Fatty Liver Disease Related Biomarkers in Women with Polycystic Ovary Syndrome (PCOS)
por: Zumbro, Emily L., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_avkt9udk4hn503nhfv8h3rjdc7